A Survey on Medicine Adoption and Appropriate Use in Hospitals in 2020

Objective: This study conducted a survey of the status of medicine adoption and appropriate use in hospitals. We compared the findings with 2015 survey results to evaluate the changes over time. We also evaluated the impact of changes in the current health care environment, including local community...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Iyakuhin jōhōgaku 2023/05/30, Vol.25(1), pp.12-23
Hauptverfasser: Kanai, Norihito, Konomura, Keiko, Ueda, Aya, Wang, Junru, Otsuka, Mayu, Akazawa, Manabu
Format: Artikel
Sprache:jpn
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 23
container_issue 1
container_start_page 12
container_title Iyakuhin jōhōgaku
container_volume 25
creator Kanai, Norihito
Konomura, Keiko
Ueda, Aya
Wang, Junru
Otsuka, Mayu
Akazawa, Manabu
description Objective: This study conducted a survey of the status of medicine adoption and appropriate use in hospitals. We compared the findings with 2015 survey results to evaluate the changes over time. We also evaluated the impact of changes in the current health care environment, including local community collaboration and the COVID-19 pandemic.Methods: The survey included 500 randomly selected hospitals with more than 200 beds, over 50% of which are general ward beds, as well as 175 hospitals that were randomly selected from the respondents of the 2015 survey. The survey questionnaire included the number of medicines, availability of medication lists, adoption decisions, and impacts of local collaboration efforts and the COVID-19 pandemic on drug adoption and appropriate use.Results: A total of 260 responses were collected from 675 hospitals (39% response rate). Of the 260 respondents, 90 were regional medical care support hospitals, 23 were special functioning hospitals, 143 were general hospitals other than those specified, and 4 were other hospital types. The average number of adopted medicines was 644 for oral medicines, 234 for topical medicines, and 228 for injectable medicines. Ninety-five percent of the hospitals used package inserts or interview forms when adopting medicines, but 15% used original articles. About 36% of the hospitals used standardized methods (hospital formulary management or protocol-based pharmacotherapy management), indicating a lack of pharmacists with pharmaceutical evaluation skills. As for local community collaboration regarding adopted medicines, the most common example was providing information to community pharmacists’ associations, and the most common method was sending information by e-mail, regardless of the hospital type. Regional collaboration meetings were few. The COVID-19 pandemic changed the method of obtaining drug information from pharmaceutical companies.Conclusion: For hospital pharmacists, the selection of adopted medicines is one of the tasks of pharmaceutical management. There are urgent needs for the use of standardized methods and the training of pharmacists involved in the selection of adopted medicines. The establishment of a system to provide appropriate use of medicine to patients by standardizing the method of medicine adoption and information sharing is desirable.
doi_str_mv 10.11256/jjdi.25.12
format Article
fullrecord <record><control><sourceid>proquest_jstag</sourceid><recordid>TN_cdi_proquest_journals_2864823055</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2864823055</sourcerecordid><originalsourceid>FETCH-LOGICAL-j825-4feff4e3b409e4412739697d2d47640dd62643e9dcc636bca9bc088dbaae01703</originalsourceid><addsrcrecordid>eNo9UE1Lw0AQXUTBUnvyDyx4Tt2d_Uhy8BCKtULFgxW8LZvsRDfUJGYTof_erRXnMDPv8XjzGEKuOVtyDkrfNo3zS1BLDmdkxrNMJBLE23nchVQJl1pekkUIDYuluVAcZmRd0Jdp-MYD7Vr6hM5XvkVauK4ffWRs62jR90PXD96OSF8DUt_STRd6P9p9OAJgwK7IRR0hLv7mnOzW97vVJtk-Pzyuim3SZKASWWNdSxSlZDlKySEVuc5TB06mWjLnNGgpMHdVpYUuK5uXFcsyV1qLjKdMzMnNyTYm-powjKbppqGNFw1kWmYgmFJRdXdSNWG072hi9k87HIwdRl_t0Rz_ZEAZ_tvgn68-7GCwFT-Oj2I8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2864823055</pqid></control><display><type>article</type><title>A Survey on Medicine Adoption and Appropriate Use in Hospitals in 2020</title><source>J-STAGE Free</source><creator>Kanai, Norihito ; Konomura, Keiko ; Ueda, Aya ; Wang, Junru ; Otsuka, Mayu ; Akazawa, Manabu</creator><creatorcontrib>Kanai, Norihito ; Konomura, Keiko ; Ueda, Aya ; Wang, Junru ; Otsuka, Mayu ; Akazawa, Manabu</creatorcontrib><description>Objective: This study conducted a survey of the status of medicine adoption and appropriate use in hospitals. We compared the findings with 2015 survey results to evaluate the changes over time. We also evaluated the impact of changes in the current health care environment, including local community collaboration and the COVID-19 pandemic.Methods: The survey included 500 randomly selected hospitals with more than 200 beds, over 50% of which are general ward beds, as well as 175 hospitals that were randomly selected from the respondents of the 2015 survey. The survey questionnaire included the number of medicines, availability of medication lists, adoption decisions, and impacts of local collaboration efforts and the COVID-19 pandemic on drug adoption and appropriate use.Results: A total of 260 responses were collected from 675 hospitals (39% response rate). Of the 260 respondents, 90 were regional medical care support hospitals, 23 were special functioning hospitals, 143 were general hospitals other than those specified, and 4 were other hospital types. The average number of adopted medicines was 644 for oral medicines, 234 for topical medicines, and 228 for injectable medicines. Ninety-five percent of the hospitals used package inserts or interview forms when adopting medicines, but 15% used original articles. About 36% of the hospitals used standardized methods (hospital formulary management or protocol-based pharmacotherapy management), indicating a lack of pharmacists with pharmaceutical evaluation skills. As for local community collaboration regarding adopted medicines, the most common example was providing information to community pharmacists’ associations, and the most common method was sending information by e-mail, regardless of the hospital type. Regional collaboration meetings were few. The COVID-19 pandemic changed the method of obtaining drug information from pharmaceutical companies.Conclusion: For hospital pharmacists, the selection of adopted medicines is one of the tasks of pharmaceutical management. There are urgent needs for the use of standardized methods and the training of pharmacists involved in the selection of adopted medicines. The establishment of a system to provide appropriate use of medicine to patients by standardizing the method of medicine adoption and information sharing is desirable.</description><identifier>ISSN: 1345-1464</identifier><identifier>EISSN: 1883-423X</identifier><identifier>DOI: 10.11256/jjdi.25.12</identifier><language>jpn</language><publisher>Tokyo: Japanese Society of Drug Informatics</publisher><subject>appropriate use ; Collaboration ; Community ; Cooperation ; COVID-19 ; COVID-19 pandemic ; Drug therapy ; evidence ; Hospitals ; Inserts ; Medicine ; Pandemics ; Pharmaceutical industry ; Pharmaceuticals ; Pharmacists ; Polls &amp; surveys ; standardized methods ; Surveys</subject><ispartof>Japanese Journal of Drug Informatics, 2023/05/30, Vol.25(1), pp.12-23</ispartof><rights>2023 Japanese Society of Drug Informatics</rights><rights>Copyright Japan Science and Technology Agency 2023</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,27901,27902</link.rule.ids></links><search><creatorcontrib>Kanai, Norihito</creatorcontrib><creatorcontrib>Konomura, Keiko</creatorcontrib><creatorcontrib>Ueda, Aya</creatorcontrib><creatorcontrib>Wang, Junru</creatorcontrib><creatorcontrib>Otsuka, Mayu</creatorcontrib><creatorcontrib>Akazawa, Manabu</creatorcontrib><title>A Survey on Medicine Adoption and Appropriate Use in Hospitals in 2020</title><title>Iyakuhin jōhōgaku</title><addtitle>JPN.J.DRUG INFOM.</addtitle><description>Objective: This study conducted a survey of the status of medicine adoption and appropriate use in hospitals. We compared the findings with 2015 survey results to evaluate the changes over time. We also evaluated the impact of changes in the current health care environment, including local community collaboration and the COVID-19 pandemic.Methods: The survey included 500 randomly selected hospitals with more than 200 beds, over 50% of which are general ward beds, as well as 175 hospitals that were randomly selected from the respondents of the 2015 survey. The survey questionnaire included the number of medicines, availability of medication lists, adoption decisions, and impacts of local collaboration efforts and the COVID-19 pandemic on drug adoption and appropriate use.Results: A total of 260 responses were collected from 675 hospitals (39% response rate). Of the 260 respondents, 90 were regional medical care support hospitals, 23 were special functioning hospitals, 143 were general hospitals other than those specified, and 4 were other hospital types. The average number of adopted medicines was 644 for oral medicines, 234 for topical medicines, and 228 for injectable medicines. Ninety-five percent of the hospitals used package inserts or interview forms when adopting medicines, but 15% used original articles. About 36% of the hospitals used standardized methods (hospital formulary management or protocol-based pharmacotherapy management), indicating a lack of pharmacists with pharmaceutical evaluation skills. As for local community collaboration regarding adopted medicines, the most common example was providing information to community pharmacists’ associations, and the most common method was sending information by e-mail, regardless of the hospital type. Regional collaboration meetings were few. The COVID-19 pandemic changed the method of obtaining drug information from pharmaceutical companies.Conclusion: For hospital pharmacists, the selection of adopted medicines is one of the tasks of pharmaceutical management. There are urgent needs for the use of standardized methods and the training of pharmacists involved in the selection of adopted medicines. The establishment of a system to provide appropriate use of medicine to patients by standardizing the method of medicine adoption and information sharing is desirable.</description><subject>appropriate use</subject><subject>Collaboration</subject><subject>Community</subject><subject>Cooperation</subject><subject>COVID-19</subject><subject>COVID-19 pandemic</subject><subject>Drug therapy</subject><subject>evidence</subject><subject>Hospitals</subject><subject>Inserts</subject><subject>Medicine</subject><subject>Pandemics</subject><subject>Pharmaceutical industry</subject><subject>Pharmaceuticals</subject><subject>Pharmacists</subject><subject>Polls &amp; surveys</subject><subject>standardized methods</subject><subject>Surveys</subject><issn>1345-1464</issn><issn>1883-423X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNo9UE1Lw0AQXUTBUnvyDyx4Tt2d_Uhy8BCKtULFgxW8LZvsRDfUJGYTof_erRXnMDPv8XjzGEKuOVtyDkrfNo3zS1BLDmdkxrNMJBLE23nchVQJl1pekkUIDYuluVAcZmRd0Jdp-MYD7Vr6hM5XvkVauK4ffWRs62jR90PXD96OSF8DUt_STRd6P9p9OAJgwK7IRR0hLv7mnOzW97vVJtk-Pzyuim3SZKASWWNdSxSlZDlKySEVuc5TB06mWjLnNGgpMHdVpYUuK5uXFcsyV1qLjKdMzMnNyTYm-powjKbppqGNFw1kWmYgmFJRdXdSNWG072hi9k87HIwdRl_t0Rz_ZEAZ_tvgn68-7GCwFT-Oj2I8</recordid><startdate>20230530</startdate><enddate>20230530</enddate><creator>Kanai, Norihito</creator><creator>Konomura, Keiko</creator><creator>Ueda, Aya</creator><creator>Wang, Junru</creator><creator>Otsuka, Mayu</creator><creator>Akazawa, Manabu</creator><general>Japanese Society of Drug Informatics</general><general>Japan Science and Technology Agency</general><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20230530</creationdate><title>A Survey on Medicine Adoption and Appropriate Use in Hospitals in 2020</title><author>Kanai, Norihito ; Konomura, Keiko ; Ueda, Aya ; Wang, Junru ; Otsuka, Mayu ; Akazawa, Manabu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j825-4feff4e3b409e4412739697d2d47640dd62643e9dcc636bca9bc088dbaae01703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>2023</creationdate><topic>appropriate use</topic><topic>Collaboration</topic><topic>Community</topic><topic>Cooperation</topic><topic>COVID-19</topic><topic>COVID-19 pandemic</topic><topic>Drug therapy</topic><topic>evidence</topic><topic>Hospitals</topic><topic>Inserts</topic><topic>Medicine</topic><topic>Pandemics</topic><topic>Pharmaceutical industry</topic><topic>Pharmaceuticals</topic><topic>Pharmacists</topic><topic>Polls &amp; surveys</topic><topic>standardized methods</topic><topic>Surveys</topic><toplevel>online_resources</toplevel><creatorcontrib>Kanai, Norihito</creatorcontrib><creatorcontrib>Konomura, Keiko</creatorcontrib><creatorcontrib>Ueda, Aya</creatorcontrib><creatorcontrib>Wang, Junru</creatorcontrib><creatorcontrib>Otsuka, Mayu</creatorcontrib><creatorcontrib>Akazawa, Manabu</creatorcontrib><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Iyakuhin jōhōgaku</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kanai, Norihito</au><au>Konomura, Keiko</au><au>Ueda, Aya</au><au>Wang, Junru</au><au>Otsuka, Mayu</au><au>Akazawa, Manabu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Survey on Medicine Adoption and Appropriate Use in Hospitals in 2020</atitle><jtitle>Iyakuhin jōhōgaku</jtitle><addtitle>JPN.J.DRUG INFOM.</addtitle><date>2023-05-30</date><risdate>2023</risdate><volume>25</volume><issue>1</issue><spage>12</spage><epage>23</epage><pages>12-23</pages><issn>1345-1464</issn><eissn>1883-423X</eissn><abstract>Objective: This study conducted a survey of the status of medicine adoption and appropriate use in hospitals. We compared the findings with 2015 survey results to evaluate the changes over time. We also evaluated the impact of changes in the current health care environment, including local community collaboration and the COVID-19 pandemic.Methods: The survey included 500 randomly selected hospitals with more than 200 beds, over 50% of which are general ward beds, as well as 175 hospitals that were randomly selected from the respondents of the 2015 survey. The survey questionnaire included the number of medicines, availability of medication lists, adoption decisions, and impacts of local collaboration efforts and the COVID-19 pandemic on drug adoption and appropriate use.Results: A total of 260 responses were collected from 675 hospitals (39% response rate). Of the 260 respondents, 90 were regional medical care support hospitals, 23 were special functioning hospitals, 143 were general hospitals other than those specified, and 4 were other hospital types. The average number of adopted medicines was 644 for oral medicines, 234 for topical medicines, and 228 for injectable medicines. Ninety-five percent of the hospitals used package inserts or interview forms when adopting medicines, but 15% used original articles. About 36% of the hospitals used standardized methods (hospital formulary management or protocol-based pharmacotherapy management), indicating a lack of pharmacists with pharmaceutical evaluation skills. As for local community collaboration regarding adopted medicines, the most common example was providing information to community pharmacists’ associations, and the most common method was sending information by e-mail, regardless of the hospital type. Regional collaboration meetings were few. The COVID-19 pandemic changed the method of obtaining drug information from pharmaceutical companies.Conclusion: For hospital pharmacists, the selection of adopted medicines is one of the tasks of pharmaceutical management. There are urgent needs for the use of standardized methods and the training of pharmacists involved in the selection of adopted medicines. The establishment of a system to provide appropriate use of medicine to patients by standardizing the method of medicine adoption and information sharing is desirable.</abstract><cop>Tokyo</cop><pub>Japanese Society of Drug Informatics</pub><doi>10.11256/jjdi.25.12</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1345-1464
ispartof Japanese Journal of Drug Informatics, 2023/05/30, Vol.25(1), pp.12-23
issn 1345-1464
1883-423X
language jpn
recordid cdi_proquest_journals_2864823055
source J-STAGE Free
subjects appropriate use
Collaboration
Community
Cooperation
COVID-19
COVID-19 pandemic
Drug therapy
evidence
Hospitals
Inserts
Medicine
Pandemics
Pharmaceutical industry
Pharmaceuticals
Pharmacists
Polls & surveys
standardized methods
Surveys
title A Survey on Medicine Adoption and Appropriate Use in Hospitals in 2020
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T16%3A39%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_jstag&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Survey%20on%20Medicine%20Adoption%20and%20Appropriate%20Use%20in%20Hospitals%20in%202020&rft.jtitle=Iyakuhin%20j%C5%8Dh%C5%8Dgaku&rft.au=Kanai,%20Norihito&rft.date=2023-05-30&rft.volume=25&rft.issue=1&rft.spage=12&rft.epage=23&rft.pages=12-23&rft.issn=1345-1464&rft.eissn=1883-423X&rft_id=info:doi/10.11256/jjdi.25.12&rft_dat=%3Cproquest_jstag%3E2864823055%3C/proquest_jstag%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2864823055&rft_id=info:pmid/&rfr_iscdi=true